Drug-Eluting Stent Market in Brazil Limited Due to Lack of Reimbursement in the Public Healthcare System

Published June 30, 2010

Drug-Eluting Stent Market in Brazil Limited Due to Lack of Reimbursement in the Public Healthcare System
According to Millennium Research Group , the global authority on medical technology market intelligence, despite the rising popularity of drug-eluting stents across Latin America, bare-metal stents will continue to represent a significant portion of the overall coronary stent market through 2014.
Read more on PR Newswire via Yahoo! Finance